Skip to content

Bifidobacterum and physical strength

The effects of Bifidobacterum on physical strength and body compositions in elderly residents: a randomized, double-blind, placebo-controlled trial - The effects of Bifidobacterum on physical strength and body compositions in elderly residents: a randomized, double-blind, placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044468
Enrollment
120
Registered
2021-06-16
Start date
2021-10-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

The participants consume 1 pack of powder containing 20 billion Bifidobacterum for 16 weeks. The participants consume 1 pack of powder not containing Bifidobacterum for 16 weeks.

Sponsors

Graduate School of Agriculture, Ehime University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 40 years old or over, and less than 85 years. (2) Applicants who understand well the purpose and contents of this trial. Additionally, who can agree to participate by his/her will.

Exclusion criteria

Exclusion criteria: 1) Persons with serious current or history of diseases (circulatory, metabolic, nervous, human immunodeficiency virus (HIV), malignant tumor, etc). 2) Allergy against milk or soybeans. 3) Intake of probiotics (foods, supplements, or drugs) twice or more times a week. 4) Participated in another clinical trial within 3 months. 5) Having disturbance in daily living activity (walking, carrying baggage, etc). 6) Judged to be ineligible by the principal investigator or doctor.

Design outcomes

Primary

MeasureTime frame
Grip strength

Secondary

MeasureTime frame
Body compositions

Countries

Japan

Contacts

Public ContactTetsu Kinoshita

Institute of Community Life Sciences Co., Ltd. Social Epidemiology Institute

tetsu.prospective@gmail.com089-904-7811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026